Characterization of endothelium-dependent vasodilation and vasoconstriction in coronary arteries from spontaneously hypertensive rats

American Journal of Hypertension

Volumn 9, Issue 5, 1996, Pages 475-483

  Fuchs, Leslie C ^a   Nuno, Dan ^c   Lamping, Kathryn G ^c   Johnson, Alan Kim ^b  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b E11 SSH   (United States)

^c NONE

Author keywords

Acetylcholine; Coronary arterioles; Endothelin 1; Hydralazine; Isoproterenol; Phenylephrine; Spontaneously hypertensive rats; Wistar Kyoto rats

Indexed keywords

ACETYLCHOLINE; ALPHA ADRENERGIC RECEPTOR; ENDOTHELIN 1; HYDRALAZINE; ISOPRENALINE; NITROPRUSSIDE SODIUM; PHENYLEPHRINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY CONSTRICTION; CORONARY ARTERY DILATATION; CORONARY ARTERY DISEASE; HEART HYPERTROPHY; HYPERTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT;

EID: 0030047120     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/0895-7061(95)00441-6     Document Type: Article

References (61)

1. Martin MJ, Browner WS, Hulley SB, et al: Serum cholesterol, blood pressure and mortality: implications from a cohort of 361,662 men. Lancet 1986;ii:933-936.
2. Stokes J, III, Kannel WB, Wolf PA, et al: Blood pressure as a risk factor for cardiovascular disease. The Framingham study - 30 years of follow-up. Hypertension 1989;13(supplI):I-13-I-18.
3. Wangler RD, Peters KG, Marcus ML, Tomanek RJ: Effects of duration and severity of arterial hypertension and cardiac hypertrophy on coronary vasodilator reserve. Circ Res 1982;51:10-18.
4. Cimini CM, Weiss HR: Microvascular morphometry and perfusion in renal hypertension-induced cardiac hypertrophy. Am J Physiol 1988;255:H1384-H1390.
5. Harrison DG, Florentine MS, Brooks LA, et al: The effect of hypertension and left ventricular hypertrophy on the lower range of coronary autoregulation. Circulation 1988;77:1108-1115.
6. Kyriakides ZS, Kremastinos DT, Michelakakis NA, et al: Coronary collateral circulation in coronary artery disease and systemic hypertension. Am J Cardiol 1991;67:687-690.
7. Alfaro A, Schaible TF, Malhotra A, et al: Impaired coronary flow and ventricular function in hearts of hypertensive rats. Cardiovasc Res 1983;17:553-561.
8. Peters KG, Wangler RD, Tomanek RJ, Marcus ML: Effects of long-term cardiac hypertrophy on coronary vasodilator reserve in SHR rats. Am J Cardiol 1984; 4:1342-1348.
9. Strauer BE: Development of cardiac failure by coronary small vessel disease in hypertensive heart disease? J Hypertens 1991;9(suppl 2):S11-S21.
10. Brush JE, Jr., Faxon DP, Salmon S, et al: Abnormal endothelium-dependent coronary vasomotion in hypertensive patients. J Am Coll Cardiol 1992;19:809-815.
11. Amrani FCE, Cheaw SL, Chevalier B, et al: Regression of left ventricular hypertrophy by converting enzyme inhibition in 12-15-month-old spontaneously hypertensive rats: effects on coronary resistance and ventricular compliance in normoxia and anoxia. J Cardiovasc Pharmacol 1994;23:155-165.
12. Bulpitt CJ, Beevers DG, Butler A, et al: The survival of treated hypertensive patients and their causes of death: a report from the DHSS Hypertensive Care Computing Project (DHCCP). J Hypertens 1986;4:93-99.
13. Julius S: Sympathetic hyperactivity and coronary risk in hypertension. Hypertension 1993;21:886-893.
14. Shea S, Cook EF, Kannel WB, Goldman L: Treatment of hypertension and its effect on cardiovascular risk factors: data from the Framingham Heart Study. Circulation 1985;71:22-30.
15. Albrecht I: The hemodynamics of early stages of spontaneous hypertension in rats. I. Male study. II. Female study. Jpn Circ J 1974;38:985-996.
16. Shepherd JT: Increased systemic vascular resistance and primary hypertension: the expanding complexity. J Hypertens 1990;8(Suppl 7):S15-S27.
17. Amezcua JL, Palmer RMJ, deSouza BM, Moncada S: Nitric oxide synthesized from L-arginine regulates vascular tone in the coronary circulation of the rabbit. Br J Pharmacol 1989;97:1119-1124.
18. Jones LF, Brody MJ: Coronary blood flow in rats is dependent on the release of vascular nitric oxide. J Pharmacol Exp Ther 1992;260:627-631.
19. Luscher TF, Vanhoutte PM, Raij L: Antihypertensive treatment normalizes decreased endothelium-dependent relaxations in rats with salt-induced hypertension. Hypertension 1987a;9(Suppl III):III-193-III-197.
20. Li F, Joshua IG: Decreased arteriolar endothelium-derived relaxing factor production during the development of genetic hypertension. Clin Exper Hypertens [A] 1993;15:511-526.
21. Treasure CB, Klein L, Vita JA, et al: Hypertension and left ventricular hypertrophy are associated with impaired endothelium-mediated relaxation in human coronary resistance vessels. Circulation 1993;87:86-93.
22. Hagen EC, Webb R: Coronary artery reactivity in deoxycorticosterone acetate hypertensive rats. Am J Physiol (Heart Circ Physiol) 1984;16:H409-H414.
23. Li J, Bukoski RD: Endothelium-dependent relaxation of hypertensive resistance arteries is not impaired under all conditions. Circ Res 1993;72:290-296.
24. Zeiher AM, Drexier H, Saurbler B, Just H: Endothelium-mediated coronary blood flow modulation in humans: effects of age, atherosclerosis, hypercholesterolemia and hypertension. J Clin Invest 1993;92:652-662.
25. Cockcroft JR, Chowienczyk PJ, Benjamin N, Ritter JM: Preserved endothelium-dependent vasodilation in patients with essential hypertension. New Engl J Med 1994;330:1036-40.
26. Webb RC, Vander AJ, Henry JP: Increased vasodilator responses to acetylcholine in psychosocial hypertensive mice. Hypertension 1987;9:268-276.
27. Brum JM, Mohara O, Ferrario CM: Endothelium masks increased vasoactivity in mineralocorticoid induced hypertension (abst). J Hypertens 1990;(suppl 3):S84.
28. Kelm M, Feelisch M, Krebber T, et al: The role of nitric oxide in the regulation of coronary vascular resistance in arterial hypertension: comparison of normotensive and spontaneously hypertensive rats. J Cardiovasc Pharmacol 1992;20(suppl 12):S183-S186.
29. Tschudi MR, Criscione L, Novosel D, et al: Antihypertensive therapy augments endothelium-dependent relaxations in coronary arteries of spontaneously hypertensive rats. Circulation 1994;89:2212-2218.
30. Tomobe Y, Ishikawa T, Yanagisawa M, et al: Mechanisms of altered sensitivity to endothelin-1 between aortic smooth muscles of spontaneously hypertensive and Wistar-Kyoto rats. J Pharmacol Exp Ther 1990; 257:555-561.
31. Wright CE, Fozard JR: Differences in regional vascular sensitivity to endothelin-1 between spontaneously hypertensive and normotensive Wistar Kyoto rats. Br J Pharmacol 1990;100:107-113.
32. Dohi Y, Lüscher TF: Endothelin in hypertensive resistance arteries: intraluminal and extraluminal dysfunction. Hypertension 1991;18:543-549.
33. Lariviere R, Thibault G, Schiffrin EL: Increased endothelin-1 content in blood vessels of deoxycorticosterone acetate-salt hypertensive but not in spontaneously hypertensive rats. Hypertension 1993;21:294-300.
34. Luscher TF, Seo B, Buhler FR: Potential role of endothelin in hypertension: controversy on endothelin in hypertension. Hypertension 1993;21:752-757.
35. Folkow B, Hallback M, Lundgren Y, Weiss L: Background of increased flow resistance and vascular reactivity in spontaneously hypertensive rats. Acta Physiol Scand 1970;80:93-106.
36. Whall CW, Jr., Myers MM, Halpern W: Norepinephrine sensitivity, tension development and neuronal uptake in resistance arteries from spontaneously hypertensive and normotensive rats. Blood Vessels 1980;17:1-15.
37. Nyborg NCB, Bevan JA: Increased α-adrenergic receptor affinity in resistance vessels from hypertensive rats. Hypertension 1988;11:635-638.
38. Schiffrin EL: Reactivity of small blood vessels in hypertension: relation with structural changes. Hypertension 1992;19(suppl II):II-1-II-9.
39. Lamping KG, Dole WP: Acute hypertension selectively potentiates constrictor responses of large coronary arteries to serotonin by altering endothelial function in vivo. Circ Res 1987;61:904-913.
40. Lüscher TF, Diederich D, Weber E, et al: Endothelium-dependent responses in carotid and renal arteries of normotensive and hypertensive rats. Hypertension 11:573-578, 1988.
41. Papapetropoulos A, Marczin N, Snead MD, et al: Smooth muscle cell responsiveness to nitrovasodilators in hypertensive and normotensive rats. Hypertension 1994;23:476-484.
42. Lüscher TF, Romero JC, Vanhoutte PM: Bioassay of endothelium-derived vasoactive substances in the aorta of normotensive and spontaneously hypertensive rats. J Hypertens 1987b;4:S81-S83.
43. Chen PY, Sanders PW: L-Arginine abrogates salt-sensitive hypertension in Dahl/rapp rats. J Clin Invest 1991;88:1559-1573.
44. Fozard JR, Part ML: Haemodynamic responses to N-monomethyl-L-arginine in spontaneously hypertensive and normotensive Wistar-Kyoto rats. Br J Pharmacol 1991;102:823-826.
45. G-Nitro arginine produces an exaggerated hypertension in anesthetized SHR. Eur J Pharmacol 1991;197:239-243.
46. Legrand MC, Benessiano J, Levy BI: Endothelium, mechanical compliance, and cGMP content in the carotid artery from spontaneously hypertensive rats. J Cardiovasc Pharmacol 1993;21(suppl 1):S26-S30.
47. Luscher TF, Dohi Y, Tschudi M: Endothelium-dependent regulation of resistance arteries: alterations with aging and hypertension. J Cardiovasc Pharmacol 1992; 19(suppl 5):S34-S42.
48. Nigro D, Fortes ZB, Carvalho MHC, Scivoletto R: Chronic, but not acute, treatment with hydralazine reverses the decreased endothelium-dependent responses in spontaneously hypertensive rats. Clin Exp Hypertens [A] 1989;A11:573-586.
49. Angus JA, Dyke AC, Jennings GL, et al: Release of endothelium-derived relaxing factor from resistance arteries in hypertension. Kidney Int 1992;37 (suppl):S73-S78.
50. Cohen DM, Webb RC, Bohr DF: Nitroprusside-induced vascular relaxation in DOCA hypertensive rats. Hypertension 1982;4:13-19.
51. Tesfamariam B, Halpern W: Endothelium-dependent and endothelium-independent vasodilation in resistance arteries from hypertensive rats. Hypertension 1988;11:440-444.
52. Jameson M, Dai FX, Lüscher T, et al: Endothelium-derived contracting factors in resistance arteries of young spontaneously hypertensive rats before development of overt hypertension. Hypertension 1993; 21:280-288.
53. Suzuki N, Miyauchi T, Tombe Y, et al: Plasma concentrations of endothelin-1 in spontaneously hypertensive rats and DOCA-salt hypertensive rats. Biochem Biophys Res Commun 1990;167:941-947.
54. Martel E, Champeroux P, Brisac AM, et al: Pressor responses to endothelin-1 in normotensive and spontaneously hypertensive rats. Neurochem Int 1991;18:553-557.
55. Korner PI, Angus JA: Structural determinants of vascular resistance properties in hypertension. J Vase Res 1992;29:293-312.
56. Tomanek RJ, Wangler RD, Bauer CA: Prevention of coronary vasodilator reserve decrement in spontaneously hypertensive rats. Hypertension 1985;7:533-540.
57. Ferrante F, Amenta F: Effect of long-term isradipine treatment on the hypertension-dependent changes in coronary arteries in spontaneously hypertensive rats. Drugs Exptl Clin Res 1991;17:363-370.
58. Jespersen LT, Nyborg NCB, Pedersen OL, et al: Cardiac mass and peripheral vascular structure in hydralazine-treated spontaneously hypertensive rats. Hypertension 1985;7:734-741.
59. Anderson PG, Bishop SP, Digerness SB: Vascular remodelling and improvement of coronary reserve after hydralazine treatment in spontaneously hypertensive rats. Circ Res 1989;64:1127-1136.
60. MacMahon W, Cutler JA, Furberg D, et al: The effects of drug treatment for hypertension on morbidity and mortality from cardiovascular disease: a review of randomized controlled trials. Prog Cardiovasc Dis 1986; 29(suppl 1):99-118.
61. Bullock JR, Taylor SG, Weston AH: No evidence for an endothelial component in the relaxant effect of hydralazine. Br J Pharmacol 1986;85:269-273.